A pilot randomized controlled trial to evaluate the benefit of the
Transcrição
A pilot randomized controlled trial to evaluate the benefit of the
Clinical Rehabilitatio n 20ffi; 2.: 125-133 A pilot randomizedcontrolledtrial to evaluatethe benefit paradigmfor the non-acute of the cardiacrehabilitation ischaemicstroke population Unit, Baggot Street Community Olive Lennon, Aisling Garey, Niamh Gaffney, Julia Stephenson Stroke Rehabilitation and PerformanceScience,UniversityCollegeDublin, lreland Hospitaland Catherine Blake School of Physiotherapy Received22nd December2006; returnedfor revisions25th February2007; revisedmanuscriptaccepted18th April 2007. qualityof life following Objective: To evaluaterisk factor reductionand health-related a 10-week cardiacrehabilitationprogramme in non-acuteischaemicstroke subjects. Des ign: S ing l e -b l i n d era d n d o mi z e dc o n tro ltri al . Setting: Outpatient rehabilitation. Subjects: Forty-eightcommunity-dwellingischaemicstroke patients (38 indepenwere randomlyassignedto dently mobile, 9 requiringassistance,1 non-ambulatory) interventionor control groups by concealedallocation. Intervention: The trial consistedof a 10-week schedulewith measurestaken at week s 1 and 1 0 . Bo th g ro u p sc o n ti n u e du s ualcare (excl udi ngaerobi cexerci se); interventionsubjects attended 16 cycle ergometry sessionsof aerobic-training intensityand two stress-managementclasses. Main outcome measures: Cardiacrisk score (CRS);MCz(mL Ozlkg per minute) and Borg Rate of PerceivedExertion(RPE)assessedduring a standardizedergometry test; HospitalAnxiety and DepressionScale(HADS);FrenchayActivity Index; Fasting Lipid P r of ile sa n d R e s ti n gB l o o d P re s s u re . Results: Group comparisonwith independentf-tests showed significantlygreater improvementat follow-up by interventionsubjectsthan controlsin VOz (intervention ) n dC R S i 0 , 6 + 1 , 6 t o 1 2 . 0 + 2 . 2 ,c o n l r o1l 1 . 1+ 1 . 8 t o 1 1 . 1+ 1 . 9 f - 4 . 7 3 4 ,P < 0 . 0 0 1 a ( i n t e r v e n t i o1n3 . 4+ 1 0 . 1 t o 12 . 4 + 1 0 . 5 ,c o n t r o l9 . 4+ 6 . 7 t o 1 5 . 0* 6 . 1 f : - 2 . 5 3 7 , P < 0. 05) .RPEra ti n gd e c re a s e di n i n te rv e nti onsubj ects(13.4 + 12.2 to 12.4* 2.0) and inc r eas edin c o n tro l s(1 3 ,8+ 1 .8 Io 1 4 .4+ 1 .6);Mann-W hi tneyU (U :173.5, P < 0.05). W it hin- gr oupc o m p a ri s o ns h o w e d s i g n i fi c antdecreasei n the H A D S depressi on s ubs c alein t h e i n te rv e n ti o ng ro u pa l o n e(5 .1+ 3.4 to 3.0 + 2.81(W i l coxonsi gnedranks t es t Z : - 3. 2 7 8 , P< 0 .0 0 1 ). G onc lus ion:Pre l i mi n a ryfi n d i n g ss u g g e s t non-acutei schaemi cstroke pati entscan fitness and reducetheir CRS with a cardiacrehabilitation imorove their cardiovascular programme.The interventionwas associatedwith improvement in self-reported depr es s ion. Address for correspondence: Olive Lennon, Stroke Rehabilitation Unit, Baggot Street Community Hospital, 18 Upper Baggot Street,Dublin 4, Ireland. e-mail: olive.lennonCalhse.ie @ SAGE Publications2008 Los Angeles,London, New Delhi and Singapore t0.tr7 7I 02692I 5507081580 126 O Lennon et al. lntroduction Cardiovascular disease and ischaemic stroke are both vascular diseases sharing many predisposing,potentially modifiable risk factors (hypertension,abnormal blood lipids and lipoproteins, cigarette smoking. plVsical inactivity, obesityand diabetesmellitus).''-Their association is not benign, with the risk of death in the stroke population, in part due to cardiac disease,at least twice that of age-matchedcontrols.' Modification of multiple risk factors through lifestyle interventions and pharmacologicaltherapy is recognized as the cornerstone of prevention of recurrent events.35 Regular physical activity and cardiac rehabilitation have proven benefits in the general population utrd port cardiac event,6-ehJwever, adoption of the cardiac rehabilitation paradigm to the ischaemicstroke population has remained untested.Stroke patients are known to have low endurance to exercise and decreased activity levelslOand few can avail themselvesof cardiovascular training through exercisecounsellingalone due to acquiied olsiultity.rr A Cochrane review and the American Stroke Association have highlighted as a priority the need for research into the efficacv and feasibilitv of aerobic exercises post stroke.2'll As adapted cycle ergometers allow aerobic this pilot study fitness training post strolel0'l-3'14 aims to establish the feasibility of a l0-week cardiac rehabilitation programme including l6 cycle ergometry sessions.Of interestis whether the programme improves: . Cardiovascularfitnessusing estimatedVO2 and Borg's Rate of PerceivedExertionl5 (RPE), at a given workload and resting heart rate (HR). . Multivariate cardiac riik scoret6 (CRS) measured by a coronary disease prediction algorithm. . Cardiovascular-metabolic risk factor profile using fasting lipid profiles and resting blood pressure. . Health-related function and quality of life as measured by the Frenchay Activity IndexlT and the Hospital Anxiety and Depression Scale.ls Methods Study design A randomized,controlled, single-blindtrial was conducted, approved by University College Dublin Human Research Ethics Committee. Measurements were made by an independent assessorblinded to allocation. Patients Subjects were recruited from the Stroke Baggot Street Rehabilitation Database, Hospital, Dublin. Information Community leafletswere posted and volunteerscontacted the research team for initial telephone screening, includingthe PAR-Q Questionnaire.re Informed consent was obtained. Participants' general practitioners were asked to notify contraindications to exercise or medication changes. All participants received a medical screeningby a physician in the stroke unit prior to participation. Sample size calculationswith 80% power and P<0.05 were conductedon the following outcome measures: . Borg's RPE15scaleto detect a 2-point change between groups indicated that a minimum of 16 subjects would be required per group (mean 17 (SD z)).tu . Hospital Anxiety and DepressionScale(HADS) depressionsubscaleto detecta2.5-pornt change betweengroups indicated a minimum of 24 per g r o u p( m e a n6 . 2( S D 3 . 1 ) ) . ' ' . Systolic blood pressurereduction of 5 mmHg indicated a minimum of 170 subjectsin each group22which was not feasible for this pilot study. Data for CRS in stroke patients was not availablefor samplesizecalculation. Inclusion criteria: >l year post ischaemicstroke (confirmedby CT or MRI scan)and over 18 years of age. Patients were included irrespectiveof their ability to ambulate independently. Exclusion criteria: 02 dependence, angina, unstablecardiac conditions,uncontrolled diabetes mellitus, major medical conditions, claudication, febrile illness' cognitive impairment or beta Pilot RTC of cardiac rehabilita:tionin stroke 127 blocker medication (RPE, a primary outcome dizziness,malaise, heart rate in excessof 60'/o maximal heart rate, oxygen saturation levels measure,was shown to be unreliable in subiects lower than g0% or participant request to stop in taking beta blocker medi cation).22'23 accordance with American Heart Association (AHA) guidelines.2a Random allocation Participants were assigned an ID number, stratified by age and sex into four blocks of six and randomly assignedusing a sequencegenerator (SPSS version 12.0), to either intervention or control groups, by an independent party. Following initial testing, participants were handed an opaque envelope which contained details of their group assignment,by clerical staff unrelated to the trial. Programme Both control and intervention subjects who were in receipt of physiotherapy and occupational therapy services continued with usual care. Occupational and physiotherapy received focused on functional activities, balance and gait. No therapy contained an aerobic exercise component. Control subjectshad a baselineassessmenton week I and re-assessment on week l0 with no additional intervention in the interim. The Cardiac Rehabilitation Programme consisted of a l0-week schedule with baseline in week 10. measuresin week I and reassessment Intervention subjects attended twice weekly for 30-minute cycle ergometry exercise (Motomed Viva 2) using either the upper or lower limbs. They exercised through biofeedback alarms set at 50-60o/oof their maximal heart rate, calculated sessionally (Karvonen formula THR (HR-u* - HR.otX50-60%) + HR.",,;. Resistance and speed were adjusted daily to ensure tailored progression.As participants did not exceed60oh max HR, the plogramme posed very low risk of adverse events.' Participants attended two life skills classes addressing stress management, relaxation and life balance. Two participants exercised concurrently in a controlled environment and all sessions were supervisedby a physiotherapist.Staff had cardiac resuscitation and defibrillation certification. Indications to stop exerciseincluded: chest pain, Measurements a Baseline descriptives includjr-rg Oxfordshire Stroke SubtypeClassification," medicalhistory including stroke, previous rcardiacevents and were noted Functional Ambulation Cal.egory26 from eachparticipant's meclicalchart. Fitnesstestinsrewas conductedwith a standardized 3-minuie submaximal rexercise test using a cycle ergometer (Reck, Mr:tomed Ywa 2) at resistancesetting 8 (5.6Nm,). Participantswere fasting overnight for 12 h<;rursat the time of testing, they were instruct,edto wear loose, comfortable clothing and room temperature was maintained at 20"C. Tht: machinepassively rpm, allowing a moved for I minute at 1!i0 warm-up and assuring ro joint discomfort. Participants took over peda.llingfor 3 minutes at a steadystate of 50rpm 'with a workload of 5.6Nm. A metronome wars present to assist with pacing. was calculated VOz (mL 9zlkg/min) (10.8x W x M ') +7, usin.gaveragewattage output during the test. RPE was rated at the end of the test, in l5 accordancewith the recomnrendedguidelines. Peak wattage was recordeil at the end of the 3-minute exercisetest. Cardiac risk scoretu(CRS) was calculated for each participant. This is arr algorithmic score based on age, resting bloocl pressure,smoking status, diabetic status, tot.al cholesterol and high-densitylipoprotein (H.DL) scores. Resting heart rate and SaO2 were measured following a 5-minute st,:ated rest period (Nanox 2 oximeter, Medlatr). Resting brachial artery blood pressure (unaffected limb) was measuredlwith a calibrated mercury sphygmomanometlerin accordance with the Joint National Committ ee YI.27 Body mass index (BMI) was calculatedusing a calibrated weighing scalesand metre rule. 128 O Lennon et al. . Fasting lipids were measured from blood samples obtained by venipuncture following overnight fasting by the subjects.Serum was analysedfor total cholesteroland triglycerides. HDL cholesterolwas determinedfrom plasma. Low-density lipoprotein (LDL) cholesterol calculatedusine the Friedewaldequation.2s . Frenchay Acti'iity IndexlT and HADSTs forms were frlled in by all participants. . Spirometry testing was performed with the participant in upright sitting using the Microlab 3300 (Micro Medical Limited). Routine use of respiratory medications including inhalerswas permitted. as such final scoresare included on patients who failed to complete the intervention.'n Change scores were compared between groups using independent l-tests where data were interval or ratio level and conformed to the assumptionsof normality. Mann-Whitney non-parametric tests were otherwise used. Ancillary analysis included single-group analysis using paired /-tests and Wilcoxon signedranks test. Results Demographic and clinical characteristicsof the intervention and control groups are presentedin Table l. Forty-eight subjectsentpredthe trial with participant flow representedin Figure 1. No change in cholesterollowering medication Data analysis Data were enteredonto the StatisticalPackage was reported in either group. Three control subfor the Social Sciences(SPSS)version 12.Analysis jects had blood pressure medication changes performed was on an intention to treat basisand during the trial: subject 4, from hypertension Table 1 Baselineand clinicaldescriotives Baselinedescriptives C o n t r o l( n : 2 4 ) Mean(SD) A c t i v el n : 2 4 1 Mean (SD) Age (years) Time since cerebrovascular accident(CVA)(weeks) 6 0 . 5( 1 0 . 0 ) 245.3(169.8) 59.0(10.3) 2 3 7 . 3( 1 1 0 . 7 ) Male Female Risht CVA Left CVA OxfordshireStroke SubtypeClassification Total anteriorcirculationinfarct(TACI) Partialanteriorcirculationinfarct(PACI) Lacunarinfarct(LACI) Posteriorcirculationinfarct(POCI) Unknown FunctionalAmbulationCategory 0 1 2 3 4 5 Known cardiachistory lschaemicheart disease Myocardialinfarct Coronaryartery bypass graft Atrial fibrillation Recurrentstroke n (ohl 14(58%) 10 (42V.1 11 (45o/ol 13 (54o/ol 1 (4.2o/ol 12 (50o/o) 5 Q0.?V.l 3l12.5%ol 3112.5%) n (o/ol 14 (58%) 10 (42o/ol 13 (54Yol 11 (450/,1 3 (12.5Vo) 9 (37.5) 7 {29.20/,1 2|,8.3V,) 3'1,12.5Yo]l 1 (4.2o/ol 218.3%ol 1 14.2o/o) 1 (4.2o/ol 6 (25o/ol 13 (54.2o/ol 0 (0%) 3112.50/"1 114.2%) 1 14.2o/o) 4'!\16.7%l 15 (62.50/ol 1 (4.2Vol 1 (4.2o/ol 0 (0olo) 2 (8.3'/ol 3 (12.5Vo) 3112.5o/ol 0 (0olo) 1 (4.2o/ol 2 (8.3o/ol 4 (16.7o/o) Pilot RTC of cardiac rehabilitation in stroke Number of patients meeting entry criteria: N= 145 Lettersretumed: n=3 Deceased: n=1 Refused: n=75 Expressedinterestn = 66 Withdrawnat initialscreening (n= 18) Reasons: On holidaysduringtrial(n = 5) On beta blockersh = 121 Unstablediabetes(n = | ) Allocatedto controlgroup(n = 24) Allocated to intervention group (n = 24) Received allocated interuention (n =2 3l *Withdrawn prior to intervention (n = 1) '(acute illness) Lostto follow-up(n = 0) Analysed(n = 231 Figure 1 Participantflow diagram. monotherapy to angiotensin II antagonist/ thiazide, subject 12 was prescribed a diuretic tablet the day before retesting and subject 34 had hypertension medication increased. Of the intervention group no change to hypertension agents was noted. Seven of the 48 subjects recruited to the study (3 control, 4 intervention) continued usual therapy as described in the programme outline. Table 2 illustrates control and intervention group scores demonstrated at baseline and follow-up. Baselinescoreswere comparedbetween groups with no significant differences noted, despite outliers in BMI and time since stroke in the intervention and control groups, respectively. Outliers were included in analysis. Between-sex differenceswere noted in baselinedata with males scoring significantly higher on forced expiratory volume in I second(FEVr) (P-0.005), peak wattage (P < 0.001) and total cholesterol(P - 0.02). 129 When change scores were compared between groups, the intervention arm demonstrated significantly greater improvements after treatment in severalprimary variableswhen comparedwith the control. Overall cardiovascular fitness improved in the intervention group with greater increasein VO2 Q 4.734,P<0.001) and decrease in RPE (U 173.5,P-0.04) by comparisonwith the controls. Cardiac risk score reduced in the intervention group but increased in the controls (t - 2.537, P - 0.015). No significant change occurred in cardiovascular-metabolic risk factor profiles of total cholesterol,LDL, HDL, triglycerides, systolic and diastolic blood pressures. Similarly, no significant difference was found in the Frenchay Activity Index or HADS change scores. Secondary outcome analysis demonstrated no significant difference in change scores between groups in spirometry results of forced vital capacity (FVC), peak expiratory flow (PEF), FEVr and FEVTIFVC (%). Peak wattage output reflecting peak power generated by the limbs during testing increasedin the intervention group comparedto the control (t 4.035,,P<0.001). When within-group analysis was performed using paired /-tests and Wilcoxon signed ranks test where appropriate, only the intervention group had a significant change in VOz (P<0.001) and cardiacrisk score(P-0.005). It is interesting to note that the HADS depression score also improved significantly in the intervention group (Z -3.278, P<0.001), but not in the control. BMI increasedin both control (P:0.008) and intervention(P :0.012) groups. Between-sex comparisonof changescoresin the intervention arm indicates both males and females benefited equally from the intervention (no significant differencesnoted). Discussion This pilot randomizedcontrolled trial study tested the feasibility of a 10-weekcardiac rehabilitation programme, demonstrating its efficacy with significant increasesin fitness parametersof VO2 and RPE and cardiac risk score reduction in the intervention group. 130 O Lennon et aI. q) o) c (o c (o 'oP c) ' Na a s?n I o ) = L q-ooqq I c 3 _o 7-\ str) o) U) 'u) (o C - : oa = LU o) = ^ o o ":l"t-c; cv)O lO)@ O rr(Y) oo$ q q O O O @ c { S CDC\N C (o _c O - - 9 - \ O O r r r | | | | F- LOCD Lriqdc-j9 - r e - O a 6 o_ c{ l - - e Q c o l s n O O O - @ - | O) I o L o_ Na- L O r O O ' l C V ) | @(rINC![OCr) el:r Nl-- (), c _c -e2a?qqq co+Nt*-.o) rCv)F. O @NNo@cf) rLOr Nf\ * Q-Q\c'{ - O - - O c U) c) U) co o o_ N il ^() c o E (t c) I (t) o_ C (E d) o_ (\ o .ct tE F c o_ t t A O C (\ o l 99e qqq ll n 8 ( o c ) F 3 r C r ) N - - q t l 99!2 qqq : -v. l E o _ 9 rf,$(o c! (Y) (O J .r.J.l qqq t r r ^ x q O \v / l l-- ; c N € a . : t l q \ S q q c ! q q - s ? Q F.sf O69N - 9 @ o ) (gO--(OrO - L o e c \ F LO(O :c!oqF_.i !-(Q-- -A 0q0qoj= \c; CY)-O-C.,t-L LU LL .:-: C! o -- \-\Cc;T cv)-o-cY)- c ) O @ l l rC\<T t t l O-Cr) E ; b -Y_ fi oC g= q q q CO$ r-c\ Lr- .y co F e)@ 9P ) g _Q> --(o-o) O) 0) ) U ;C') : t'N |f) l C9 i U Cr.l @ N + + H N + H 1 +t + + 9 qq={cloq \-e..ne (osto)tor U) c n s-r_ d t l LO +++++ +++++= o _ ( N O O O O - - I\ o qoqqQ-9 r l-'.<iQ c (D u l-- .- $ QqQ'.\ C) (o ! c P P P f o - L I J J qqq (O r r r $ qdoqeloi. a o_ o - o o _ ; g d i l t + l - l # + + r + + 1 1+ + 9 (D - ( I +r+H+r# HH+l++D qqnq9 \qc'{qc2q Cv)$O(g-CD@ O LO -'; i . q . q : |S X ..3hq e t O - O - C ) ] J r r r l - - -t l ; o * 3 P O l o u C + I * s 6 (Y) crl - * t = qn\ # * ^ + : : 0) o ( E : o ( o O l q- (l) l \ -. <. +. r: f n el. e.t. O. o. LOO$@CY) Ol--OOO) t t t l l l l sf@O o$r-. q q \ q O O O o [ i O(OONcv) (\Ntr)CDrO oo)-osf, a ? - Q Q Q O O O O O I d Loo-rl:$ rtf)NF 6-6G - N S t t =9D q q q iD ,lQ l r= (O (O e\ ^E I g;U EF EE =E E; ISrse'Ei- :e-.'sE EEt= n t s v L ; ;i O; Lv U' a Y P I I .9.Eo= C n P 9 6f l n . X ; = 5a E o; f u O O C ; o o o o - i i F'Ixo*6 L th vt - (o.n ll E r Eg:d-;b E ' b *P E > .- 9>E3 it; iH[eE :frre r;sIEE - 53FE X c O- i s:;e?3 3 , + ? E . o rsq 53E "' E ? !Bs P f:rs r E; b Eg f n3F E E cg XU 9^ tEs >N E gP#8H?? Tg$Ep#FE#r ( U - P L r?€8o€ Pilot RTC of cardiac rehabilitatibn in stroke 131 No significant improvements were noted in rehabilitation in coronary heart disease8has health-related quality of life (HRQoL) indices demonstrateda net reduction in total cholesterol or cardiovascular-metabolicprofiles. Decreased and LDL in comprehensivecardiac rehabilitation HADS depressionscoreson final testing in the groups but not in exercise-only interventions. active group does however suggestan associated As both groups in this study demonstrated no increase in well-being. As a pilot study with significant change in lipoprotein profiles relatively small numbers, limited power to and increasesin BMI over the trial period, it demonstrate health status and functional bene- suggests future interventions should involve dietary education. fits exists. Two coronary heart disease trials33'34noted Another limitation of the methodology in both systolicand diastolic employed in this study is that the control group favourabledecreases did not receive comparable non-exerciserelated blood pressure in comprehensive cardtac attention to the intervention group. Thus there programmes. However, systematicreview noted an increasein blood pressure over trial periods may be a potential Hawthorn effect. The Cochrane Review on Physical Fitness in both groups in a number of studies.uAs Training in Stroke Patientslt drtuils only two increases were more marked in the control studies including measures of aerobic fitness groups, the net changeswere considerednegative. (VO) and maximal work rate (Watts)r0'30and This study demonstrateda drop in systolic blood two meeting the American College of Sports pressure in both groups and an increase in Medicine (ACSM) guidelines for developing diastolic blood pressure in both groups. 15ir study complies A number of subjectsin the control group had cardiorespiratoryfitness.t0'31 with cardiovasculartraining requirementsby the a change in hypertension medications over the rigour of the training programme described and course of the trial but no change in medication similar improvements in fitness parameters VOz noted in the intervention grolrp, suggesting a and RPE were observed in this study. As no possible trend toward blood pressure reduction aerobic training component was included in in the intervention group. Higher cardiac risk scoresin the intervention usual therapy, common to both groups, these changes may be attributed to the intervention. group occurred because, despite randomization, It has been demonstrated in the literature that the intervention arm contained three more stroke patients can improve their fitness levels to people with diabetesthan the control. This status the same deqree as their aee-matchedcounter- does not change from initial to final testing. parts.r0 This"study, througli deployment of the Similarly both groups contained six smokersand CRS outcome measure,demonstratesthe benefit 17 non-smokers,with smoking status remaining unchanged on final testing. Therefore the cardiac of such interventionson vascularrisk reduction. Previous studies noted that improvement in risk reduction scoreswere as a result of alteration RPE and VO2 cannot distinguish between central of resting blood pressureand fasting cholesterol This was also measurements. While no significant change and peripher-al adaptation.'10'32 observed in this study with a significant increase was seen in either variable in isolation, when in peak wattage in the intervention group consideredin the context of a weighted algorithcompared to the control, indicating that a lower mic score, cardiac risk scoreswgre reduced in the limb muscle training effect must be consideredas intervention group. Given the absenceof change well as central cardiac adaptation to the exercise in cholesterollowering medicationsin both groups programme. and pharmacologicalmanagementof hypertension cardiac rehabilitation in the interventiongroup, this may be attributed to Comparison with programmes for the coronary heart disease the programme. The authors acknowledgethe cardiac risk score populations is limited as primary outcome measures of mortality and non-fatal cardiac algorithm usedis not validatedfor non-caucasians events were not feasible in the short time-frame (subject 1; intervention group) and those over and limited subject numbers in this pilot 74 years old (subject 13; control and subject 19; study. However, meta-analysisof exercise-based intervention). Analysis of cardiac risk change 132 O Lennon et al. scoreswith thesesubjects' data removed however, References continues to demonstrate significantly greater cardiac risk reduction in the intervention group I Heart Health Task Force. Ireland's Changing Heart. Department of Health and Children, 2003. ( t - 2 . 5 1 2 ,P - 0 . 0 1 6 ) . 2 Gordon NF, Gulanick M, Costa F et al. Physical Modification of all major cardiovascularrisk activity and exerciserecommendationsfor stroke factors, including physical inactivity, is reported survivors.Circulation2004;1tD9:203l-41. to be cost-effectivebut needsto be better tarseted 3 Adams RJ, Chimowitz MI, A,lpert JS e/ al. AHAI for potential health gain.35 ASA Scientific Statement.Coronary risk evaulaNo study to date has looked at reducing tion in patients with transient.ischemicattack and vascular risk profiles in ischaemicstroke through ischemic stroke. Circulation 2003: 108: 1278-90. adoption of the cardiac rehabilitation paradigm. 4 Chalmers J, Chapman N. Ch,allengesfor the Thesefindings show promise for suchprogrammes prevention of primary and ser;ondarystroke: the importanceof lowering bloodipressureand total as preventative interventions for further stroke cardiovascularrtsk. Blood Press2001; l0:344-51. and cardiac events. Using baseline data from 5 Wolf PA, Clagett GP, Easton JD et a/. Preventing this study, sample size estimation (n>2Kotl\' ischemic stroke in patients wirth prior stroke and (K:7.8)) suggestsa minimum of 120 subjects transient ischemicattack: a st.atementfor healthin each group would be required to show care professionalsfrom the SrlrokeCouncil of the expectedchange in all primary outcome measures AHA. Stroke 1999:30:l99l-94. in a definitive studv. to be conducted bv this 6 PearsonTA, Blair SN, Daniels SR et al. AHA researchgroup. guidelinesfor primary prevenl.ionof cardiovascular 7 Clinical messages . Ischaemic stroke patients have high risk of coronary heart disease and recurrent stroke. . Stroke patients are known to have low exercise endurance. o Submaximal aerobic training is both safe and feasiblein chronic stroke using adapted cycle ergometry. . The cardiac rehabilitation paradigm adapted to stroke reducescardiac risk and increases aerobic fitness in chronic ischaemic stroke patients. 8 9 10 II Acknowledgementsand funding Heart Health ResearchBursary, Health Service Executive, Ireland 2004. Ethical approval was granted by University College Dublin, Human 12 Research Ethics Sub-Committee, University CollegeDublin, Belfield,Dublin 4, Ireland. All authors state no conflict of interestexistsin this body of research. diseaseand stroke. Circulation2002;106: 388-91. Fletcher FG, Blair SN, Blum,enthalJ et al. Statement on exercises,benefits,and recommendation for physical activity programs for all Americans: a statementfor hrlalth professionals by the committee on exerciseand cardiac rehabilitation of the council on clinical cardiology, American heart association.L7irculation1992;86: 34M4. Jolliffe JA, ReesK, Taylor RS, Thompson D, rehabilitaOldridge N, Ebrahim S. Exercise-based tion for coronary heart disease.CochraneDatabase SystRev 200l,Issuel. Article no: CD001800.DOI: 10.1002 I r46sl 8s8.cD00 l 800. Taylor RS, Brown A, Ebrahim S et al. Exercisebased rehabilitation for patients with coronary revie'wand meta-analysis heart disease:systematic of randomized controlled trials. Am J Med 2004: 116:682 92. PotempaK, Lopez M, Braun I, Szidon P, Fogg L, Tincknell T. Physiologicaloutcomesof aerobic training in hemipareticstroke patients.Stroke 19952 ; 6: 101-105. Hill K, Ellis P, Bernhardt J, -MaggsP, Hull S. Balanceand mobility outcomesfor stroke patients: a comprehensiveaudit. Aust -I Physiother1997:43: 17380. SaundersDH, Greig CA, Young A, Mead GE. Physical fitness training for slroke patients. CochraneDatabaseSyst Rev 2004,Issuel. Article no: CD0033l6.pub2.DOI: 10.10021 1465I 858.CD0033 I 6.pub2 Pilot RTC of cardiac rehabilitation in stroke l 3 Carr J, ShepherdR. Stroke rehabilitation:guidet4 l5 l6 t7 l8 l9 21 25 linesfrtr erercise and training to optimize motor skill. Butterworth Heinemann, 2003. Brinkmann JR, Hoskins TA. Physicalconditioning and altered self-conceptin rehabilitated hemiplegic patients. Phys Ther 1979;7: 859 65. Borg G. Borg's perceivedexertion and pain scales. Human Kinetics, 1998. Wilson PW, D'Agostino RB, Levy D, BelangerAM, SilbershatzH, Kannel WB. Prediction of coronary heart diseaseusing risk factor categories.Circulation 1998;97: 1837-47. Holbrook M, Skilbeck CE. An activities index for use with stroke patients. Age Ageing 1983; 12: 166 70. Zigmond AS, Smith RP. The hospital anxiety and depressionscale.Acta Psychiatry Scand 1983;67: 361 370. American Collegeof Sports Medicine. ACSM's guidelinesfor exercisetestingand prescription.sixth edition. Lippincott Williams and Wilkins, 2000: 165- 93. Fletcher BJ, Dunbar SB, Felner JM et a/. Exercise testing and training in physically disabledmen with clinical evidenceof coronary artery disease.Am J Cardiol 1994:73: 170-74. Wade DT, Collen FM, Robb GF, Warlow CP. Physiotherapy intervention late after stroke and mobility. BMJ 1992;304:609-13. Eng JJ, Chu KS, Dawson AS, Kim CM, Hepburn KE. Functional walk testsin individuals with stroke. Relationship to perceivedexertion and myocardial exertion. Stroke 2002; 33: 756-61. Derman EW, Sims R, Noakes TD. The effects of anti-hypertensivemedications on the physiological responseto maximal exercisetesting. J Cardiovasc Pharmacol Ther 1992; 19: 122-26. Gibbons RJ, Balady GJ, BeasleyJW et al. A report of the American college of cardiology/American Heart associationtask force on practice guidelines (Committee on ExerciseTesting). J Am Coll Cardiol 1997;30: 260-31L Dewey H, Macdonell R, Donnan G, FreemanE, Thrift A, Sharples.Inter-rater reliability of stroke sub-type classificationby neurologistsand nurses 26 27 28 29 30 3l 32 33 133 within a community-basedstroke incidence study. J Clin Neurosci2001;8: 14-17. Holden MK, Gill KM, Magliozzi MR, Nathan J, Piehl-Baker L. Gait assessmentfor the neurologically impaired: reliability and meaningfulness.Phys Ther 1984:64:35 40. Joint Committee on Prevention.Detection. Evaluation and Treatment of High Blood Pressure (JNCVI), Public Health Service,National Institute of Health, NIH PublicationNo. 98-4080, November 1997. FriedewaldWT, Levy RT, FredericksonDS. Estimation of VLDL- and LDl-cholesterol. Clin Chem 1972: l8: 499-502. Hollis S, Campbell F. What is meant by intention to treat analysis?Survey of published randomised controlled trials. BMJ 1999,319: 670-74. da Cunha IT, Lim PA, QureshyH, Henson H, Monga T,, Protas EJ. Gait outcomesafter acute stroke rehabilitation with supported treadmill training. A randomisedcontrolledpilot study.Arch Phys Med Rehabil 2002;83: 1258-65. Teixeira-SamelaLF, Nadeau S, McBride I, Olney SJ. Muscle strengtheningand physical conditioningto reduceimpairment and disability in chronic stroke survivors. Arch Phys Med Rehabil 1 9 9 9 ; 8 0 :l 2 1 1 - 1 8 . Landin S, HagenfedltL, Saltin B, Wahren J. Muscle metabolism during exercisein hemiparetic patients.Clin Med Sci Mol Med 1997:53:257 69. WHO Helsinki: Kallio V, Hamalainen H, Hakkila J, Luurila OJ. Reduction in sudden deaths by a multifactorial intervention programme after acute myocardial infarcti on. Lancet 1979;2(8152): r09r-94. 34 Haskell WL, Aldeffnamn EL, Fair JM et a/. Effects of intensivemultiple risk factor reduction on coronary atherosclerosisand clinical cardiac events in men and women with coronary artery disease:The Stanford Coronary Risk Intervention Project (SCRIP). Circulation 1994;89: 975-90. 35 Ebrahim S. Systematicreview of cost-effectiveness researchof stroke evaluation and treatment. Stroke 1999:30: 2759-60.